Abstract
Background Systemic sclerosis (SSc) is a multisystem autoimmune disorder that has an unclear etiology and disproportionately affects women and African Americans. Despite this, African Americans are dramatically underrepresented in SSc research. Additionally, monocytes show heightened activation in SSc and in African Americans relative to European Americans. In this study, we sought to investigate DNA methylation and gene expression patterns in classical monocytes in a health disparity population.
Methods Classical monocytes (CD14++CD16-) were FACS-isolated from 34 self-reported African American women. Samples from 12 SSc patients and 12 healthy controls were hybridized on MethylationEPIC BeadChip array, while RNA-seq was performed on 16 SSc patients and 18 healthy controls. Analyses were computed to identify differentially methylated CpGs (DMCs), differentially expressed genes (DEGs), and CpGs associated with changes in gene expression (eQTM analysis).
Results We observed modest DNA methylation and gene expression differences between cases and controls. The genes harboring the top DMCs, the top DEGs, as well as the top eQTM loci were enriched for metabolic processes. Genes involved in immune processes and pathways showed a weak upregulation in the transcriptomic analysis. While many genes were newly identified, several other have been previously reported as differentially methylated or expressed in different blood cells from patients with SSc, supporting for their potential dysregulation in SSc.
Conclusions While contrasting with results found in other blood cell types in largely European-descent groups, the results of this study support that variation in DNA methylation and gene expression exists among different cell types and individuals of different genetic, clinical, social, and environmental backgrounds. This finding supports the importance of including diverse, well-characterized patients to understand the different roles of DNA methylation and gene expression variability in the dysregulation of classical monocytes in diverse populations, which might help explaining the health disparities.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work is supported by the US National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (NIH) under Awards Number R03 AR065801 (PSR), P30 AR072582 (JF, GSG, PSR), P60 AR062755 (GSG, PSR), by the Scleroderma Foundation (PSR), the MUSC Center for Genomic Medicine (PSR), and the American College of Rheumatology Career Development Bridge Funding Award: K Bridge (DBF). Supported in part by the Cell Evaluation & Therapy Shared Resource and by the Flow Cytometry and Cell Sorting Shared Resource, Hollings Cancer Center, Medical University of South Carolina (P30 CA138313).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Institutional Review Board at the Medical University of South Carolina (Pro# 33636).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
New supplemental files added and methodological details clarified.
Data Availability
The gene expression and DNA methylation data presented in this study are openly available in the NCBI Gene Expression Omnibus (GEO) repository (Accession codes GSE196071 for the study, GSE196007 for the DNA methylation, and GSE196070 for the transcriptomic data). All data are also available from the authors on request. All code to reproduce these analyses is available at https://github.com/PeterCAllen/scleroderma_monocyte_analysis.
List of abbreviations
- CpGs
- cytosine-phosphate-guanine sites
- DEG
- differentially expressed genes
- DMC
- differentially methylated CpG
- eQTM
- expression quantitative trait methylation
- lcSSc
- limited cutaneous SSc
- dcSSc
- diffuse cutaneous SSc
- FDR
- false discovery rate
- SSc
- systemic sclerosis
